spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

ELRIG Drug Discovery 2019 – Looking Back to the Future

ELRIG_Drug_Discovery_

5-6 November 2019
ACC, Liverpool

Drug Discovery 2019 Plenary Keynote Speakers: Mene Pangalos (AstraZeneca) Fiona Marshall (MSD) The tracks for Drug Discovery 2019 cover the following key areas: • Cellular Models of Disease • Chemical biology – re-defining target and therapeutic class tractability? • Big Data and Artificial Intelligence • Targeting Ion Channels for Drug Discovery hosted by the British Pharmacological Society • Molecular and Cellular Imaging • Biomarkers Strategies in Drug Discovery • Hit Finding Strategies • Oncology in Drug Discovery hosted by Cancer Research UK Drug Discovery has become the largest meeting of life sciences industry professionals in the UK. This 2-day event will bring together more than 1200 delegates and over 100 exhibiting companies from around the world who will highlight the latest ground- breaking research, discuss cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel chemical and biological candidate drugs. To maximize the interaction between delegates and exhibitors/sponsors, our programme includes scientific poster sessions, coffee/tea and lunch breaks that are located within the vendor exhibition area and a drinks/networking reception on the first day. The meeting is free-of-charge to all delegates and include complimentary refreshments and lunch.
phone +44 (0) 7484113971
email info@elrig.org
web https://elrig.org/portfolio/2019-drug-discovery/
email ACC, Liverpool
 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>


News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement